Restlet Engine Reaches 1.0

Noelios Consulting releases Version 1.0 of its Restlet Engine for building RESTful Java applications.

Noelios Consulting has announced Version 1.0 of its Noelios Restlet Engine, the reference implementation of the Restlet API 1.0.

The Restlet open-source project was launched at the end of 2005 as a Representational State Transfer, or REST, framework for Java. Jerome Louvel, founder and consultant with Noelios, is the creator of the Restlet engine.

Several applications have been deployed in production using the Restlet Engine, including Overstock.com, as well as supporting technology for software architecture classes covering the REST architecture style at the University of California Irvine and the INSA (Institut National des Sciences Appliquées, or translated as France's National Institute of Applied Sciences) Rouen engineering school.

The open-source Restlet Engine NRE is a stand-alone Web platform delivered through a set of pluggable extensions. The engine can integrate with technologies such as the Spring Framework and Servlet containers like Apache Tomcat, Louvel said.

Noelios will provide professional support and consulting services around Restlet and related technologies, including Java, XML and REST.

The goal of the framework is to provide a reusable and extendable set of classes and interfaces that will serve as a foundation for developers to build their own applications more efficiently, Louvel said. He said he created NRE because there was no Java framework available to help developers easily build so-called RESTful applications.

Noelios is based in Levallois Perret, France.

Copyright 2007 by Ziff Davis Media, Distributed by United Press International

Citation: Restlet Engine Reaches 1.0 (2007, April 15) retrieved 26 April 2024 from https://phys.org/news/2007-04-restlet.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Genetically engineered cell therapies with mRNA lipid nanoparticles for transferrable platelets

0 shares

Feedback to editors